Loading Page..

Knowledge Content Library

282
DA Implementation Planning: DAAG 2012 Breakout Results
Presented by Ellen Coopersmith (Decision Frameworks) at 2012 DAAG Conference in Chicago. The session enabled dialogue and understanding of key elements necessary for successful DA implementation and how DAAG companies are progressing.

283
Rethinking Decision Analysis
Presented by Gregory Parnell at 2012 DAAG Conference in Chicago. Decision analysts can benefit from the best practices in both single and multiple objective decision analysis, including application of these ideas in a Cyberspace Investment Planning Model for Air Force Space Command.

284
Project Portfolio Management Best Practices Summary of Results
Presented by Michael Menke (Value Creation Associates) at 2012 DAAG Conference in Chicago. A benchmarking study captures the practices and pitfalls in PM. Generic recommendations are available and should be considered by those practitioners wishing to make improvements and impacts.

285
Processes and Tools of Portfolio Management: A Baxter Case Study
Presented by Phil Beccue (Baxter) at 2012 DAAG Conference in Chicago. Case study touches upon evolution of portfolio methods, where the organization is today, where it is headed with regards to PM. Includes challenges addressed along with perspectives from others in Baxter.

286
Should you create project level alternatives in portfolios?
Presented by Jeffrey Kiesler (University of Massachusetts) at 2012 DAAG Conference in Chicago. One way that portfolio decision analysis adds value is by improving the set of alternatives from which we choose. This set can be enriched by generating multiple alternatives involving different amounts of funding at the project level.

287
The use of decision analysis for Phase 2 and Phase 3 drug development decisions
Presented by Elayne Ko (Deloitte) and Charles Persinger (Eli Lilly) at 2012 DAAG Conference in Chicago. The characteristics of drug development in Phase 2 and 3 are explored, and the implications of applying decision analysis process for the Phase 2 and 3 drug development decisions are highlighted.

288
Everything We Know is Wrong - Leach
Presented by Pat Leach (Decision Strategies) at 2012 DAAG Conference in Chicago. All of the logic, intuition, and metrics humans have for making decisions were developed during a time when resources were abundant, populations were relatively small, and we could focus on maximizing returns today because tomorrow always held new frontiers. None of this is true anymore.

289
Decision Analysis Without Jargon or Models or DA as a Natural Act
Presented by Rob Kleinbaum (RAK) at 2012 DAAG Conference in Chicago. Applications of decision analysis in which monetization and jargon were deliberately avoided. These interactions were intentionally designed to help decision makers gain clarity of action through a quality decision process without monetary rollbacks, NPVs or fancy, highfalutin, special language.

264
Multi-attribute Decision Analysis
Presented by Dave Charlesworth (Chevron) at 2011 DAAG Conference in Houston. What is Multi‐attribute Decision Analysis and when should it be used? Common mistakes, protocol for executing the analysis, and case studies.

265
Soft Skills are DA Skills Too: Overview of Soft Skills Workshop
Presented by Paul Wicker (Decision Strategies) and Jack Kloeber (Kromite) at 2011 DAAG Conference in Houston. Notes from a workshop on soft skills, including an example of eliciting risk attitude from decision makers.

266
Decision Consulting at Eli Lilly and Company: A Journey (History, Evolution and Challenges)
Presented by Charles Persinger (Eli Lilly) at 2011 DAAG Conference in Houston. History and lessons learned from decision consulting within Eli Lilly.

267
Probabilistic Modeling to Support and Facilitate Decision Making in Early Drug Development
Presented by Huybert Groenendaal (EpiX Analytics) at 2011 DAAG Conference in Houston. Overview of use of probabilistic methods to combine wide range of data sources into one decision supporting model.

268
Technology Selection Decision: With the Shoe on the Other Foot
Presented by Jerry Lieberman and Rick Mauro (Endeavor Management) at 2011 DAAG Conference in Houston. Discussion of how technology decisions should be treated as business investments.

269
Decision Analysis - Comparison of Pharmaceutical & Upstream Oil
Presented by Vish Viswanathan (Chevron) at 2011 DAAG Conference in Houston. Comparison of the similarities and differences in the use of Decision Analysis in Pharma and Oil & Gas.

270
Risk & Uncertainty (R&U) Benchmarking and Insights
Presented by Jeremy Brann, Steve Letros, Ashu Patwardhan, Kevin Powell (Shell) at 2011 DAAG Conference in Houston. Risk & Uncertainty Benchmarking is a data repository for an individual Projects R&U data - the objective of the activity is to perform Risk and Uncertainty for project comparisons.

271
Understanding the Value of Simops Decisions on Well Planning and Execution Using Decision Analysis
Presented by Leslie Armentrout (Hess) at 2011 DAAG Conference in Houston. Example of decision analysis applied to simultaneous operations of high risk activities (Simops) in well planning.

272
Cleaner Analysis: Quicker Decision, Three Examples from Government
Presented by Mark Powell (Attwater Consulting) at 2011 DAAG Conference in Houston. Three examples of the issues encountered when making technical decisions for government projects, including two NASA projects and one US Coast Guard project.

273
Theory, Best Practices, and An Illustrative Example
Presented by Gregory Parnell (US Military Academy) at 2011 DAAG Conference in Houston. Discussion and examples of defining objectives and metrics for measuring them.

274
Survey of Value‐Focused Thinking: Applications, Research Developments, and Areas for Future Research
Presented by Dave Hughes, Greg Parnell, Roger Burk, Pat Driscoll, Paul Kucik, Ben Morales, Lawrence Nunn (US Military Academy) at 2011 DAAG Conference in Houston. Goal is to provide a comprehensive summary of the significant applications of Value Focused Thinking, describe the main research developments, and identify areas for future research.

275
The Art of Making the Right Thing Happen
Presented by Rob Kleinbaum (RAK) at 2011 DAAG Conference in Houston. If DA practitioners want to become more effective at changing their company, they must become more adept at creating a culture of profitability.

Stay connected